Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (71-80 of 738) with videos related to

Pageof 74
Sort By:
Anesthesiology|November 1, 1983
No effect of hyperbaric oxygen on methionine synthetase activity in ratsN M Sharer, S J Monk, J F Nunn
Gynecologic Oncology Research and Practice|June 8, 2017
Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapyBrett A Miles, Bradley J Monk, Howard P Safran
Frontiers in Systems Neuroscience|March 22, 2021
Visual Cues Predictive of Behaviorally Neutral Outcomes Evoke Persistent but Not Interval Timing Activity in V1, Whereas Aversive Conditioning Suppresses This ActivityKevin J Monk, Simon Allard, Marshall G Hussain Shuler
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian CancerBradley J Monk, Leslie M Randall, Rachel N Grisham
Toxicology Letters|November 1, 1981
Effect of high helium and hydrostatic pressure on bacterial mutation and growthJ M Baden, S J Monk, M J Halsey
Spine|March 2, 2005
The mannequin signAnthony Westbrook, Amol Tambe, Kanthalu Subramanian, et al.
Clinical Chemistry|March 1, 1989
Oligoclonal banding in serum from heart-transplant recipientsJ Monk, J Calvin, C P Price, et al.
Gynecologic Oncology|April 5, 2021
Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delayDana M Chase, Jordan Neighbors, Jessica Perhanidis, et al.
Gynecologic Oncology|July 21, 2004
Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapyAnnie Yessaian, Alessandra Magistris, Robert A Burger, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2021
DNA Damage Repair Inhibitors-Combination TherapiesGabriella Smith, Zachary Alholm, Robert L Coleman, et al.
Pageof 74

Showing results (71-80 of 738) with videos related to

Sort By:
Pageof 74
Anesthesiology|November 1, 1983
No effect of hyperbaric oxygen on methionine synthetase activity in ratsN M Sharer, S J Monk, J F Nunn
Gynecologic Oncology Research and Practice|June 8, 2017
Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapyBrett A Miles, Bradley J Monk, Howard P Safran
Frontiers in Systems Neuroscience|March 22, 2021
Visual Cues Predictive of Behaviorally Neutral Outcomes Evoke Persistent but Not Interval Timing Activity in V1, Whereas Aversive Conditioning Suppresses This ActivityKevin J Monk, Simon Allard, Marshall G Hussain Shuler
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian CancerBradley J Monk, Leslie M Randall, Rachel N Grisham
Toxicology Letters|November 1, 1981
Effect of high helium and hydrostatic pressure on bacterial mutation and growthJ M Baden, S J Monk, M J Halsey
Spine|March 2, 2005
The mannequin signAnthony Westbrook, Amol Tambe, Kanthalu Subramanian, et al.
Clinical Chemistry|March 1, 1989
Oligoclonal banding in serum from heart-transplant recipientsJ Monk, J Calvin, C P Price, et al.
Gynecologic Oncology|April 5, 2021
Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delayDana M Chase, Jordan Neighbors, Jessica Perhanidis, et al.
Gynecologic Oncology|July 21, 2004
Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapyAnnie Yessaian, Alessandra Magistris, Robert A Burger, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2021
DNA Damage Repair Inhibitors-Combination TherapiesGabriella Smith, Zachary Alholm, Robert L Coleman, et al.
Pageof 74